Topics Covered:
- Identify important issues related to adolescent and young adult cannabis use and cannabis-related disorders during this era of changing cannabis legalization
- Describe the effects of early adolescent exposure to cannabis and cannabinoids, including Δ9-THC and CBD, on neurodevelopment, psychosocial, and health outcomes
- Discuss assessment, diagnosis, and treatment of cannabis use disorders in youth
- Formulate evidence-informed treatment plans for youth cannabis use disorders that incorporate evidence-based psychosocial interventions and, when appropriate, adjunctive medication treatment strategies to improve outcomes.
Watch the Presentation
View the Learner Notification
Click to claim your credit [/colorsection] [center] [colorsection bgcolor=”darkbluebg”]About the Speaker
[one_third]
[/one_third]
[two_third_last]
Presented by: Christopher Hammond, MD, PhD | Triple Board-Certified General Psychiatrist, Child & Adolescent Psychiatrist, & Addiction Medicine Physician
Dr. Christopher Hammond is a triple board-certified general psychiatrist, child & adolescent psychiatrist, and addiction medicine physician, and an Associate Professor of Psychiatry & Behavioral Sciences in the Division of Child & Adolescent Psychiatry at Johns Hopkins University School of Medicine (SOM) with secondary appointments in the Behavioral Pharmacology Research Unit (Substance Abuse Services), Department of Pediatrics, and Division of Adolescent/Young Adult Medicine. He has over 10 years of clinical and research experience working with children and families affected by substance use and addictive disorders and has published extensively on clinical best practices in this area. Dr. Hammond serves as Director of the Co-occurring Disorders in Adolescents & Young Adults (CODA) Clinical and Research Programs at Johns Hopkins University SOM.
[/two_third_last]
[/colorsection]
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Galen Mental Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
The Role of Safety Behaviors in Maintaining Mental Health Conditions
Presented By:
Christopher Hammond, MD
June 21st, 2024
- Identify important issues related to adolescent and young adult cannabis use and cannabis-related disorders during this era of changing cannabis legalization
- Describe the effects of early adolescent exposure to cannabis and cannabinoids, including Δ9-THC and CBD, on neurodevelopment, psychosocial, and health outcomes
- Discuss assessment, diagnosis, and treatment of cannabis use disorders in youth
- Formulate evidence-informed treatment plans for youth cannabis use disorders that incorporate evidence-based psychosocial interventions and, when appropriate, adjunctive medication treatment strategies to improve outcomes.
Video: Watch the Presentation
Presented by:Christopher Hammond, MD, PhD Triple Board-Certified General Psychiatrist, Child & Adolescent Psychiatrist, & Addiction Medicine Physician
Dr. Christopher Hammond is a triple board-certified general psychiatrist, child & adolescent psychiatrist, and addiction medicine physician, and an Associate Professor of Psychiatry & Behavioral Sciences in the Division of Child & Adolescent Psychiatry at Johns Hopkins University School of Medicine (SOM) with secondary appointments in the Behavioral Pharmacology Research Unit (Substance Abuse Services), Department of Pediatrics, and Division of Adolescent/Young Adult Medicine. He has over 10 years of clinical and research experience working with children and families affected by substance use and addictive disorders and has published extensively on clinical best practices in this area. Dr. Hammond serves as Director of the Co-occurring Disorders in Adolescents & Young Adults (CODA) Clinical and Research Programs at Johns Hopkins University SOM.
Joint Accreditation Statement:
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Galen Mental Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
